tiprankstipranks

Andrew Craig Miller Insider Profile

4 Followers
Andrew Craig Miller, President of R&D at Karuna Therapeutics, holds 11.01K shares in Kyverna Therapeutics, Inc. (Ticker: KYTX), holds 0.00 shares in Karuna Therapeutics (Ticker: KRTX), holds ― shares in Alto Neuroscience, Inc. (Ticker: ANRO).
tipranks
Andrew Craig Miller

Andrew Craig Miller
Karuna Therapeutics (KRTX)
President of R&D

Not Ranked
Andrew Craig Miller has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$94K
100.00%
0.00%
A breakdown of Andrew Craig Miller's holdings

Insider Roles

Kyverna Therapeutics, Inc.
(KYTX)
Director
Alto Neuroscience, Inc.
(ANRO)
Director
Roles that Andrew Craig Miller holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Andrew Craig Miller

Andrew Craig Miller's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KRTX
Karuna Therapeutics
Mar 18, 2024
Uninformative Sell
7.72M
$0.00
Kyverna Therapeutics, Inc.
Mar 04, 2026
Director
Uninformative Buy
$93.77K
Alto Neuroscience, Inc.
Director
List of latest transactions for each holding click on a transaction to see Andrew Craig Miller's performance on stock

Andrew Craig Miller insider profile FAQ

What is the percentage of profitable transactions made by Andrew Craig Miller?
The percentage of profitable transactions made by Andrew Craig Miller is ―.
    What is the average return per transaction made by Andrew Craig Miller?
    The average return per transaction made by Andrew Craig Miller is ―.
      What stocks does Andrew Craig Miller hold?
      Andrew Craig Miller holds: KRTX, KYTX, ANRO stocks.
        What was Andrew Craig Miller’s latest transaction?
        Andrew Craig Miller latest transaction was an Uninformative Buy of ―.
          What was Andrew Craig Miller's most profitable transaction?
          Andrew Craig Miller’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Andrew Craig Miller's role in Karuna Therapeutics?
            Andrew Craig Miller's role in Karuna Therapeutics is President of R&D.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.